Lorus
Therapeutics Inc.
Notice
of Annual General and Special Meeting of Shareholders
NOTICE
IS HEREBY GIVEN that the annual general and special meeting of
shareholders (the “Meeting”) of Lorus Therapeutics Inc. (the
“Corporation”) will be held at The
Exchange Tower, 130 King Street West, Toronto, Ontario on
Thursday, November 18, 2004 at 4:00 p.m. (Toronto time) for the following
purposes:
1. to
receive
the financial statements of the Corporation for the financial year ended
May 31,
2004, together with the report of the auditors thereon;
2. to
appoint
auditors and to authorize the directors to fix the remuneration to be paid
to
the auditors;
3. to
elect
directors;
4. to
consider
and if thought fit pass a resolution ratifying the amendment to the
Corporation’s 1993 Stock Option Plan to extend the expiry date of options
granted under the 1993 Stock Option Plan from five years to 10 years,
as set
forth in Appendix “B” to the accompanying management information
circular;
5. to
consider
and if thought fit pass a resolution ratifying the amendments to
By-law No. 1 of
the Corporation, as set forth in Appendix “C” to the accompanying management
information circular; and,
6. to
transact
such other business as may properly come before the Meeting or
any adjournment
thereof.
The
accompanying management information circular provides additional information
relating to the matters to be dealt with at the Meeting and forms part of
this
notice.
If
you are not able to be present at the Meeting, please exercise your right
to
vote by signing and returning the enclosed form of proxy to Computershare
Trust
Company of Canada, 100 University Avenue, 8th Floor,
Toronto,
Canada M5J 2Y1, so as to arrive not later than 5:00 p.m. on Tuesday, November
16, 2004 or, if the Meeting is adjourned, 48 hours (excluding Saturdays,
Sundays
and holidays) before any adjournment of the Meeting.
BY
ORDER OF THE BOARD OF DIRECTORS
|
(signed)
SHANE A. ELLIS
|
Toronto,
Canada
|
Vice
President of Legal Affairs and
|
October
7, 2004
|
Corporate
Secretary
|